SCHEMBL20066646

SCHEMBL20066646

COc1ccc(N(c2ccc(OC)cc2)c2ccc3c(c2)C(c2ccccc2)(C2(c4ccccc4)c4ccccc4-c4ccc(N(c5ccc(OC)cc5)c5ccc(OC)cc5)cc42)c2ccccc2-3)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 5/20 0.41
▸ OPRM1 P35372 1/20 0.39
▸ OPRL1 P41146 1/20 0.39
▸ ABL1 P00519 1/20 0.36
▸ ABCB1 P08183 1/20 0.36
▸ BCR P11274 1/20 0.36
▸ SLC6A3 Q01959 2/20 0.35
▸ MAPT P10636 4/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ RPS6KA2 Q15349 1/20 0.35
▸ CA4 P22748 1/20 0.34
▸ LTA4H P09960 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ MAOA P21397 1/20 0.34
▸ PTGS2 P35354 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20066897 0.96 OPRM1 (0.42) PDK2OPRM1OPRL1ABL1ABCB1
SCHEMBL20066552 0.87 PDK2 (0.41) PDK2MAPTKMT2ASMN1; SMN2KDM4E
SCHEMBL16996132 0.86 PDK2 (0.41) PDK2OPRM1OPRL1ABL1ABCB1
SCHEMBL16996425 0.85 PDK2 (0.40) PDK2OPRM1OPRL1ABL1ABCB1
SCHEMBL21364231 0.85 PDK2 (0.40) PDK2OPRM1OPRL1ABL1ABCB1
SCHEMBL17903090 0.85 OPRM1 (0.41) PDK2OPRM1OPRL1ABL1ABCB1
SCHEMBL20066639 0.85 PDK2 (0.38) PDK2OPRM1OPRL1MAPTCES1
SCHEMBL21031614 0.85 OPRM1 (0.42) PDK2OPRM1OPRL1ABL1ABCB1
SCHEMBL16996137 0.83 PDK2 (0.46) PDK2OPRM1OPRL1ABL1ABCB1
SCHEMBL20159380 0.83 PDK2 (0.44) PDK2ABL1ABCB1BCRSLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10907093-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2021-02-02 — — US disclosed
US-20180105741-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-04-19 — — US disclosed
US-20180105741-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-04-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180105741-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME C1S, SCO2, CCND2 PDK2 1507/4885OPRM1 1597/4885OPRL1 506/4885
US-10907093-B2 Condensed cyclic compound and organic light-emitting device including the same C1S, SCO2, CCND2 PDK2 1507/4885OPRM1 1597/4885OPRL1 506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback